David Lillicrap, MD, discusses AAV gene therapy in a canine hemophilia model

• Date :
• 8    
  0

6 Month Data From the Phase 3 Etranacogene Dezaparvovec HOPE-B Gene Therapy Trial

• Date :
• 1    
  0

Dr. Steven W. Pipe discusses the latest on BAY 2599023

• Date :
• 1    
  0

Valoctocogene Roxaparvovec AAV Gene Transfer for Severe Hemophilia: Results From Phase 3 Trial

• Date :
• 1    
  0

An update on HOPE B Gene Therapy Trial from Stevne Pipe, MD

• Date :
• 0    
  0

Liver Safety Case Report From the Phase 3 HOPE-B Gene Therapy Trial in Adults With Hemophilia B

• Date :
• 0    
  0

9ème Journée Nationale Maladies Rares Immuno-Hématologiques - MaRIH 2023

• Date :
• 3380    
  6

International Society on Thrombosis and Haemostasis congress - ISTH 2023

• Date :
• 4963    
  0

The European Hematology Association - EHA 2023

• Date :
• 8092    
  0

MDS - 17th International Congress on Myelodysplastic Syndromes

• Date :
• 12637    
  0

43e congrès annuel de la Société Française d’Hématologie - SFH 2023

• Date :
• 9346    
  7